Connor, Clark & Lunn Investment Management (CC&L)’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-148,046
| Closed | -$555K | – | 1604 |
|
|
2024
Q1 | $555K | Buy |
+148,046
| New | +$555K | ﹤0.01% | 1076 |
|
|
2021
Q1 | – | Sell |
-206,007
| Closed | -$5.34M | – | 1063 |
|
|
2020
Q4 | $5.34M | Buy |
+206,007
| New | +$5.34M | 0.03% | 324 |
|
|
2015
Q4 | – | Sell |
-21,578
| Closed | -$79K | – | 853 |
|
|
2015
Q3 | $79K | Sell |
21,578
-67,300
| -76% | -$246K | ﹤0.01% | 675 |
|
|
2015
Q2 | $512K | Sell |
88,878
-29,100
| -25% | -$168K | ﹤0.01% | 423 |
|
|
2015
Q1 | $689K | Sell |
117,978
-110,400
| -48% | -$645K | 0.01% | 355 |
|
|
2014
Q4 | $1.79M | Buy |
228,378
+1,000
| +0.4% | +$7.84K | 0.01% | 240 |
|
|
2014
Q3 | $1.12M | Buy |
+227,378
| New | +$1.12M | 0.01% | 283 |
|